Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
Recruiting
Observational Study
Neoplasm Malignant
Body Weight
Quality of Life
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,380 (estimated)
- Sponsor
- University of Rome Tor Vergata · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
BMI is a simple and widely recorded variable that may capture obesity or cachexia in cancer patients. How BMI is associated to health-related quality of life (HR-QoL) in such patients is poorly investigated.
High BMI may be associated to obesity, an increased burden of comorbidity, reduced physical activity and, in some settings, to more aggressive oncological disease. On the other hand, low BMI …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Histologically confirmed diagnosis of solid tumor
2. Age \>18 years
3. Signed informed consent
4. Life expectancy \> 12 weeks
Exclusion Criteria:
1. Inability to fill out the EORTC QLQ-C30 questionnaire.
2. Absence of a certain diagnosis of solid tumor (e.g. subjects on scr…
Contacts